Predictive and prognostic potential of pretreatment 68Ga-PSMA PET tumor heterogeneity index in patients with metastatic castration-resistant prostate cancer (mCRPC).

被引：0
|
作者：
Assadi, Majid
Manafi-Farid, Reyhaneh
Jafai, Esmail
Keshavarz, Ahmad
Divband, GhasemAli
Moradi, Mohammad Mobin
Adinehpour, Zohreh
Samimi, Rezvan
Dadgar, Habibollah
Mayer, Benjamin
Prasad, Vikas
机构：
[1] Bushehr Univ Med Sci, Bushehr, Iran
[2] Univ Tehran Med Sci, Tehran, Iran
[3] Persian Gulf Univ, Bushehr, Iran
[4] Khatam PET CT Ctr, Tehran, Iran
[5] Shahid Beheshti Univ, Tehran, Iran
[6] Razavi Hosp, Canc Res Ctr, Mashhad, Iran
[7] Univ Ulm, Ulm, Germany
[8] Univ Hosp Ulm, Ulm, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
200
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Predictive biomarkers in circulating tumor cells to direct management metastatic castration-resistant prostate cancer (mCRPC)
    Scher, Howard I.
    Schonhoft, Joseph
    Dittamore, Ryan
    CANCER RESEARCH, 2019, 79 (13)
  • [32] Atypical metastatic pattern of prostate cancer detected with 68Ga-PSMA PET/CT
    Fech, Viktor
    Sachpekidis, Christos
    Alberts, Ian
    Rominger, Axel
    Afshar-Oromieh, Ali
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2020, 59 (02): : 85 - 86
  • [33] The role of Ga68 PSMA PET/CT imaging in Lu177 PSMA treatment planning in metastatic castration-resistant prostate cancer
    Erdogan, Mehmet
    Sengul, Sevim S.
    Cetin, Bulent
    Avci, Mustafa
    Yagci, Samet
    Ozkoc, Ismail
    Barikan, Damla Ezgi
    Yildiz, Mustafa
    ANNALS OF NUCLEAR MEDICINE, 2022, 36 (06) : 562 - 569
  • [34] The Utility of 68Ga-PSMA PET/CT in Poorly Differentiated Metastatic Prostate Cancer
    Demirkol, Mehmet Onur
    Kiremit, Murat Can
    Acar, Omer
    Ucar, Burcu
    Saglican, Yesim
    CLINICAL NUCLEAR MEDICINE, 2017, 42 (05) : 403 - 405
  • [35] The role of Ga68 PSMA PET/CT imaging in Lu177 PSMA treatment planning in metastatic castration-resistant prostate cancer
    Mehmet Erdogan
    Sevim S. Sengul
    Bulent Cetin
    Mustafa Avcı
    Samet Yagci
    Ismail Ozkoç
    Damla Ezgi Barikan
    Mustafa Yildiz
    Annals of Nuclear Medicine, 2022, 36 : 562 - 569
  • [36] Comparison of Tumor Heterogeneity Assessed with Textural Parameters in 68Ga-PSMA PET/CT and 177Lu-PSMA SPECT/CT in Patients with Metastatic Prostate Cancer
    Schwarte, L.
    Thomas, L.
    Eppard, E.
    Meisenheimer, M.
    Weiss-Wichert, C.
    Essler, M.
    Bundschuh, R. A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S345 - S345
  • [37] Circulating tumor DNA (ctDNA) and correlations with clinical prognostic factors in patients with metastatic castration-resistant prostate cancer (mCRPC).
    Khalaf, Daniel
    Annala, Matti
    Beja, Kevin
    Vandekerkhove, Gillian
    Zulfiqar, Muhammad
    Finch, Daygen L.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [38] Stereotactic Radiotherapy to Oligoprogressive Lesions Detected With 68Ga-PSMA-PET/CT in Castration-Resistant Prostate Cancer Patients
    Onal, C.
    Ozyigit, G.
    Oymak, E.
    Guler, O. C.
    Tilki, B.
    Hurmuz, P.
    Akyol, F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E289 - E289
  • [39] Stereotactic radiotherapy to oligoprogressive lesions detected with 68Ga-PSMA-PET/CT in castration-resistant prostate cancer patients
    Onal, Cem
    Ozyigit, Gokhan
    Oymak, Ezgi
    Guler, Ozan Cem
    Tilki, Burak
    Hurmuz, Pervin
    Akyol, Fadil
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (11) : 3683 - 3692
  • [40] Stereotactic radiotherapy to oligoprogressive lesions detected with 68Ga-PSMA-PET/CT in castration-resistant prostate cancer patients
    Cem Onal
    Gokhan Ozyigit
    Ezgi Oymak
    Ozan Cem Guler
    Burak Tilki
    Pervin Hurmuz
    Fadil Akyol
    European Journal of Nuclear Medicine and Molecular Imaging, 2021, 48 : 3683 - 3692
12345